Chaperones, ROS systems, & IGF-1:Roles in vascular aging
Chaperones, ROS systems, & IGF-1:Roles in vascular aging
批准号:
7458880
负责人:
DAVID Robert CLEMMONS
金额:
$151.01万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-01 至 2010-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The major purpose of this proposal is to investigate the molecular mechanisms that regulate phenotypic changes that occur in blood vessel walls during aging in mice. The investigators will use several experimental animal models to investigate the roles of three physiologic regulatory systems that have each been shown to modify the response to stress. These include reduction in insulin like growth factor I (IGF-I) signaling, which in lower organisms has been shown to enhance the heatshock protein response to stress and the ability to survive oxidative stress as well as modifications of age related changes in multiple tissues. These studies will determine if this finding in lower organisms extends to mice and if a particular receptor subtype (e.g. growth hormone or IGF-I) mediates this response, A second system that will be examined is regulation of generation of reactive oxygen species. The roles of superoxide dismutase 1 and 2 (SOD-1 & 2) in altering vascular aging will be investigated by altering their expression as well as p47 phox and then determine the outcome on the aging vascular phenotype. The interactions between changes in these components and changes in IGF-I and CHIP function and how they modify the vascular aging response will be defined, Gene profiling will be used to identify other molecular changes that occur when ROS are increased. A third series of studies will investigate the role of molecular chaperones in controlling age-related changes in the vasculature. The role of CHIP, a modifier of the heat shock protein response to stress, in altering the response to ROS manipulation and in lesion formation will be investigated. The role of modifying these genes in altering the atherosclerotic response that occurs in response to vascular injury will be examined. Femoral arteries will be denuded and the atherosclerotic lesions that form after 14-28 days analyzed to determine the role of each of these components in lesion progression. Several types of genetically altered mice will be crossed with APOE deficient mice and the development of spontaneous hypercholesterolemic induced atherosclerotic lesions will be analyzed. The results should define the relationship between alteration of each of these signaling systems and both the development of the aging vascular phenotype and in neointimal formation. Since there are interactions between IGF-I signaling, ROS system generation and expression of CHIP in controlling both IROS production and IGF-I signaling, analysis of the interactions among each of these three systems may provide further insight into molecular mechanisms that regulate these changes in normal vessel walls and their roles in supporting neointimal formation.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.freeradbiomed.2013.04.001
发表时间:
2013-08
期刊:
FREE RADICAL BIOLOGY AND MEDICINE
影响因子:
7.4
作者:
[Madamanchi, Nageswara R., Runge, Marschall S.]
通讯作者:
Runge, Marschall S.
DOI:
10.1080/15287394.2017.1420504
发表时间:
2018
期刊:
Journal of toxicology and environmental health. Part A
影响因子:
--
作者:
[Carter JD, Madamanchi NR, Stouffer GA, Runge MS, Cascio WE, Tong H]
通讯作者:
Tong H
DOI:
10.1016/j.yjmcc.2016.12.004
发表时间:
2017-01
期刊:
Journal of molecular and cellular cardiology
影响因子:
5
作者:
[Lozhkin A, Vendrov AE, Pan H, Wickline SA, Madamanchi NR, Runge MS]
通讯作者:
Runge MS
DOI:
10.5482/hamo-14-11-0076
发表时间:
2016-05-10
期刊:
Hamostaseologie
影响因子:
3.2
作者:
[Sun QA, Runge MS, Madamanchi NR]
通讯作者:
Madamanchi NR
Determination of the Mechanisms by which IGFBP-2 Stimulates Bone Remodeling
-
批准号:8722439
-
项目类别:
-
资助金额:$45.06万
-
财政年份:2011
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
Determination of the Mechanisms by which IGFBP-2 Stimulates Bone Remodeling
-
批准号:8306113
-
项目类别:
-
资助金额:$45.99万
-
财政年份:2011
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
Determination of the mechanisms by which IGFBP-2 stimulates bone remodeling
-
批准号:8190538
-
项目类别:
-
资助金额:$47.26万
-
财政年份:2011
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
Determination of the Mechanisms by which IGFBP-2 Stimulates Bone Remodeling
-
批准号:8900755
-
项目类别:
-
资助金额:$45.98万
-
财政年份:2011
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
Determination of the Mechanisms by which IGFBP-2 Stimulates Bone Remodeling
-
批准号:8528338
-
项目类别:
-
资助金额:$43.69万
-
财政年份:2011
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
CLINICAL TRIAL: METFORMIN ON CHANGES IN AMPKINASE ACTIVITY IN PERIPHERAL BLOOD
-
批准号:7716900
-
项目类别:
-
资助金额:$0.53万
-
财政年份:2008
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
ATORVASTATIN ON PLASMA CHOLINE CONCENTRATION IN SUBJECTS WITH AND WITHOUT THE ME
-
批准号:7716914
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2008
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
Development of a Novel Method for Inhibiting Atherosclerosis in Diabetes
-
批准号:7109891
-
项目类别:
-
资助金额:$21.03万
-
财政年份:2006
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
IGF-1 POLYMORPHISM OF DIABETIC AND PREDIABETIC SUBJECTS AND ASSOCIATED INSULIN
-
批准号:7625549
-
项目类别:
-
资助金额:$0.66万
-
财政年份:2006
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
IGF-1 POLYMORPHISM OF DIABETIC AND PREDIABETIC SUBJECTS AND ASSOCIATED INSULIN
-
批准号:7377480
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2005
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
IGF-1 SIGNALING AND VASCULAR AGING
-
批准号:6828193
-
项目类别:
-
资助金额:$38.45万
-
财政年份:2004
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
Chaperones, ROS systems, & IGF-1:Roles in vascular aging
-
批准号:7255567
-
项目类别:
-
资助金额:$149.6万
-
财政年份:2004
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
Chaperones, ROS systems, & IGF-1:Roles in vascular aging
-
批准号:6942567
-
项目类别:
-
资助金额:$147.15万
-
财政年份:2004
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
Chaperones, ROS systems, & IGF-1:Roles in vascular aging
-
批准号:6815236
-
项目类别:
-
资助金额:$141.83万
-
财政年份:2004
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:6828186
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2004
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
Chaperones, ROS systems, & IGF-1:Roles in vascular aging
-
批准号:7084446
-
项目类别:
-
资助金额:$149.58万
-
财政年份:2004
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
IGF-1/IGFBP-3 on Lipoprotein Subfractions and Insulin Sensitivity in Patients
-
批准号:6980644
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2003
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
IGF-1 polymorphism of diabetic and prediabetic subjects and associated insulin
-
批准号:6980726
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2003
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
ATHEROSCLEROSIS IN INSULIN-RESISTANT, HYPERLIPIDEMIC PTS
-
批准号:6440013
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2001
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
ARTHEROSCLEROSIS IN INSULIN-RESISTANT, HYPERLIPIDEMIC P*
-
批准号:6528147
-
项目类别:
-
资助金额:$52.99万
-
财政年份:2001
-
负责人:DAVID Robert CLEMMONS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ROS/TXNIP/NLRP3信号通路介导的细胞焦亡途径探讨慢阻肺舒颗粒对慢性阻塞性肺疾病急性加重期(AECOPD)痰热壅肺证大鼠模型的干预机制
-
批准号:2026JJ80947
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李柯
-
依托单位:
基于巨噬细胞MPO缺失的线粒体ROS/KLF4通路对动脉粥样硬化斑块不稳定性的机制研究
-
批准号:2026JJ82110
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄江伟
-
依托单位:
SIRT3/FoxO3a/ROS通路介导的铁死亡在脓毒症肌肉萎缩中的作用及机制研究
-
批准号:2026JJ30096
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢鹏
-
依托单位:
抗阻训练激活ROS/PRDX3/FUNDC1信号轴调控线粒体自噬延缓肌少症的机制研究
-
批准号:JCZRQNB202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ROS响应性泡沫细胞靶向调节脂质稳态治疗动脉粥样硬化
-
批准号:2026JJ81260
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邓丹
-
依托单位:
双功能COFs基S型异质结的精准构建及其光催化产H2O2驱动ROS级联杀菌的机制研究
-
批准号:2026JJ80004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张淑敏
-
依托单位:
IDO1源性线粒体ROS介导血水草提取物原阿片碱抗血小板聚集
-
批准号:2026JJ80210
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:轩贵平
-
依托单位:
基于pH/ROS智能响应的大黄酸仿生水凝胶构建及其调控OA炎症微环境促进软骨再生的作用机制
-
批准号:2026JJ70138
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘之晨
-
依托单位:
大黄酸通过PPARG/SHMT1/NOX1轴抑制ROS依赖性血管平滑肌细胞焦亡改善慢性肾衰竭血管钙化的机制研究
-
批准号:2026JJ82590
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:熊丹
-
依托单位:
姜黄素脂质体协同CDK4/6抑制剂通过ROS/DNA损伤通路阻遏乳腺癌转移的机制研究
-
批准号:JCZRLH202600107
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: